TRANSCON
Ascendis Pharma A/S
Mark For: TRANSCON® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79221044 |
| Registration Number | 5881763 |
| Mark Literal Elements | TRANSCON |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2019-10-15 |
| Basis | 66(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | Yes |
| Current Basis | No |
| No Basis | No |
| Domestic Representative | Paul F Kilmer |
| Attorney Name | Paul F Kilmer |
| Attorney Docket Number | 115191.00010 |
| Law Office Assigned | N40 |
| Employee Name | PAPALE, LISA ANNE |
Timeline
| 2017-07-17 | Application Filed |
| 2019-07-30 | Published |
| 2019-07-30 | Published for Opposition |
| 2019-10-15 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-10-15 | Status: Live/Registered |
| 2019-10-15 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2019-10-15 | Trademark Registered |
| 2019-10-15 | Transaction Date |
| 2024-10-15 | Maintenance Early File Date |
| 2025-10-15 | Maintenance On Time Date |
| 2026-04-15 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  Ascendis Pharma A/S |
| Address | Tuborg Boulevard 5 DK-2900 Hellerup DENMARK |
| Legal Entity Type | Public Limited Company |
| Legal Entity State | DENMARK |
Documents
Application
DrawingAttorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and veterinary preparations, namely, a drug delivery system in the form of polymer based prodrug formulations which allow for the controlled or continuous release of a wide variety of therapeutic agents for the treatment of mental illness and physical illness in the nature of disorder of the endocrine system, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor (FGFR)-related skeletal disorders, oncology, ophthalmology, infectious disease, enzyme replacement therapy, anti-inflammatory disease, pain, respiratory system disorder, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wound healing; sanitary preparations for medical purposes; dietetic substances adapted for medical use; disinfectants; fungicides; herbicides
IC 042. US 100 101. G & S: Scientific research within the medical, pharmaceutical and bacteriological area and consultancy and information relating thereto; conducting of tests regarding medical applications in the nature of providing medical testing services in the field of sustained release of pharmaceutical and veterinary drugs; designing and development of medical equipment; designing pharmaceutical and medical preparations in the nature of pharmaceutical drug development services; development of pharmaceutical formulations; design and development of pharmaceutical granulation technology and pharmaceutical tablet technology and consultancy and information relating thereto
IC 045. US 100 101. G & S: Licensing of industrial property rights; legal services
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 45 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical and veterinary preparations, namely, a drug delivery system in the form of polymer based prodrug formulations which allow for the controlled or continuous release of a wide variety of therapeutic agents for the treatment of mental illness and physical illness in the nature of disorder of the endocrine system, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor (FGFR)-related skeletal disorders, oncology, ophthalmology, infectious disease, enzyme replacement therapy, anti-inflammatory disease, pain, respiratory system disorder, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wound healing; sanitary preparations for medical purposes; dietetic substances adapted for medical use; disinfectants; fungicides; herbicides |
| GS0051 | Pharmaceutical and veterinary preparations, namely, a drug delivery system in the form of polymer based prodrug formulations which allow for the controlled or continuous release of a wide variety of therapeutic agents for the treatment of mental illness and physical illness in the nature of disorder of the endocrine system, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor (FGFR)-related skeletal disorders, oncology, ophthalmology, infectious disease, enzyme replacement therapy, anti-inflammatory disease, pain, respiratory system disorder, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wound healing; sanitary preparations for medical purposes; dietetic substances adapted for medical use; disinfectants; fungicides; herbicides |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-02-21 | |
| FINAL DISPOSITION NOTICE SENT TO IB | 2020-02-04 | |
| FINAL DISPOSITION PROCESSED | 2020-02-03 | 73787 |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-01-15 | |
| REGISTERED-PRINCIPAL REGISTER | 2019-10-15 | |
| NOTIFICATION PROCESSED BY IB | 2019-08-23 | |
| PUBLISHED FOR OPPOSITION | 2019-07-30 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-07-30 | |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2019-07-10 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-07-10 | |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2019-07-10 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-06-21 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2019-06-20 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2019-06-20 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2019-06-20 | 93057 |
| EXAMINER'S AMENDMENT ENTERED | 2019-06-20 | 88888 |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2019-05-03 | |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2019-04-17 | |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2019-04-17 | |
| REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2019-01-11 | 70884 |
| SUSPENSION LETTER WRITTEN | 2018-07-11 | 93057 |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2018-07-11 | 6332 |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-07-11 | 6328 |
| LETTER OF SUSPENSION E-MAILED | 2018-07-11 | 6332 |
| EXAMINERS AMENDMENT E-MAILED | 2018-07-11 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2018-07-11 | 93057 |
| EXAMINER'S AMENDMENT ENTERED | 2018-07-11 | 88888 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-06-21 | 70884 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-06-21 | 70884 |
| ASSIGNED TO LIE | 2018-06-20 | 70884 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-06-06 | |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-02-23 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-02-23 | |
| REFUSAL PROCESSED BY IB | 2017-12-29 | |
| REFUSAL PROCESSED BY MPU | 2017-12-08 | 67445 |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2017-12-08 | |
| APPLICATION FILING RECEIPT MAILED | 2017-11-28 | |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2017-11-26 | |
| NON-FINAL ACTION WRITTEN | 2017-11-25 | 93057 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-11-22 | |
| ASSIGNED TO EXAMINER | 2017-11-22 | 93057 |
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2017-11-16 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 